Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.20 and has seen 5.49 million shares traded in the last trading session. The company, currently valued at $14.65M, closed the last trade at $0.17 per share which meant it lost -$0.02 on the day or -7.22% during that session. The TNXP stock price is -2105.88% off its 52-week high price of $3.75 and 0.0% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.59 million shares traded. The 3-month trading volume is 1.95 million shares.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Sporting -7.22% in the red in last session, the stock has traded in the red over the last five days, when the TNXP stock price touched $0.17 or saw a rise of 15.84%. Year-to-date, Tonix Pharmaceuticals Holding Corp shares have moved -56.97%, while the 5-day performance has seen it change -6.77%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have changed -52.73%. Short interest in the company has seen 0.97 million shares shorted with days to cover at 0.76.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
Figures show that Tonix Pharmaceuticals Holding Corp shares have outperformed across the wider relevant industry. The company’s shares have lost -69.57% over the past 6 months, with this year growth rate of 56.06%, compared to 9.20% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 58.50% and 47.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 115.90%.
1 analysts offering their estimates for the company have set an average revenue estimate of $7.5 million for the current quarter. 1 have an estimated revenue figure of $7.9 million for the next quarter concluding in Jun 2024.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 79.31% over the past 5 years.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next earnings report between March 12 and March 15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Insiders own 0.01% of the company shares, while shares held by institutions stand at 28.61% with a share float percentage of 28.61%. Investors are also buoyed by the number of investors in a company, with Tonix Pharmaceuticals Holding Corp having a total of 48 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 0.4 million shares worth more than $0.63 million. As of Jun 29, 2023, Vanguard Group Inc held 2.24% of shares outstanding.
The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 0.21 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $0.33 million and represent 1.19% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2023, the former fund manager holds about 1.67% shares in the company for having 0.3 million shares of worth $0.47 million while later fund manager owns 0.1 million shares of worth $0.16 million as of Jun 29, 2023, which makes it owner of about 0.57% of company’s outstanding stock.
